MedTrace Logo

FLOTOR Pilot Study

NCT03292757 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2018-11-19

No results posted yet for this study

Summary

This is a non-randomised study assessing the technique of using indocyanine green as a fluorescent dye to highlight the thoracic duct during oesophectomy.

Conditions

  • Chylothorax
  • Esophageal Cancer
  • Thoracic Duct Intra-Operative Injury

Interventions

DRUG

Indocyanine Green

Fluorescent dye - indocyanine green

Sponsors & Collaborators

  • Oxford University Hospitals NHS Trust

    lead OTHER

Principal Investigators

  • Richard Gillies, MBChB · Consultant Upper GI Surgeon

  • Thomas Barnes, MBChB · Clinical Research Fellow

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-12-20
Primary Completion
2018-08-20
Completion
2018-09-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03292757 on ClinicalTrials.gov